Journal Paper

Paper Information

Journal:
Year:0 | Volume: | Issue:
Start Page: | End Page:

video

sound

Persian Version

View:

19,921

Download:

14,174

Cites:

Information Journal Paper

Title

CHITOTRIOSIDASE ACTIVITY AND GENE POLYMORPHISM IN IRANIAN PATIENTS WITH GAUCHER DISEASE AND SIBLING CARRIERS

Writers

 MOZAFARI HADI

Pages

 Start Page 62 | End Page 70

Abstract

 Objective Chitotriosidase (CT) activity is a useful biomarker for diagnosis and monitoring of GAUCHER DISEASE (GD). Its application is limited by some variants in the CT gene. Two main POLYMORPHISMs are 24 bp duplication and G102S led to reduce CT activity. The aim of this study was to determine these variants influencing on plasma CT activity.Materials & Methods Blood samples were collected from 33 patients with GD, 15 sibling carriers and 105 healthy individuals serving as controls. CT activity was measured using 4-methylumbelliferyl-β-D-N, N′, N″triacetylchitotrioside substrate in plasma samples. The CT genotypes of 24 bp duplication and G102S variants were determined using PCR and PCR-RFLP.Results Untreated GD patients had a significantly higher CT activity compared to treated patients (P=0.021). In addition, chitotriosidase activity in carriers was higher rather than controls. Allele frequencies of 24 bp duplication in GD patients, sibling carriers and controls were 0.21, 0.266 and 0.29 and for G102S were 0.318, 0.366 and 0.219, respectively. Different G102S genotypes had not significant effect on CT activity. Chitotriosidase activity has a positive correlation with age in normal group, carriers, and negative correlation with hemoglobin in GD patients. Using cut-off level of 80.75 nmol/ml/h, sensitivity and specificity of CT activity were 93.9% and 100%, respectively.Conclusion Chitotriosidase activity is a suitable biomarker for diagnosis and monitoring of GD. Determination of 24 bp duplication is helpful for more accurate monitoring the GD patient’s therapy. However, it seems that, specifying of the G102S POLYMORPHISM is not required for Iranian GD patients.

Cites

  • No record.

    • References

  • No record.

    • Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops